ABBV · News · 20260829N

Guidance / Outlook

AbbVie Inc. · 2026-08-29 · Importance 47 · Surprise 60

AbbVie trimmed its full-year 2026 EPS guidance slightly after reporting second-quarter results. The revision indicates a more cautious management outlook despite Q2 revenue of $16.99 billion exceeding consensus estimates. The report provides no specific revised EPS range or quantified financial impact from the change.

Key facts